Internationally known stroke expert Tudor Jovin, MD, medical director of Cooper and Inspira Neuroscience and Professor of Neurology and Neurological Surgery at Cooper Medical School of Rowan University, is the co-principal investigator and co-lead author of a study published today in The New England Journal of Medicine which demonstrates the benefits of treating stroke patients with severe brain damage.
The IN EXTREMIS-LASTE (Large Stroke Treatment Evaluation) study, led by researchers from Montpellier University Medical Center in France (Vincent Costalat, MD, PhD, Professor of Neurology and Chief of Neuroradiology Department and Caroline Arquizan, MD, Chief of Neurovascular Department), in collaboration with researchers from Hospital Foch in Paris, France (Bertrand Lapergue, MD, PhD and Chief of Neurology and Neurovascular Department) and from Cooper University Health Care focused on stroke patients with severe brain damage due to blocked blood vessels without any restrictions in the size of seemingly irreversibly damaged brain as ascertained by brain imaging studies. Read more.